Review
Cognitive dysfunction in unipolar depression: Implications for treatment

https://doi.org/10.1016/j.jad.2013.09.012Get rights and content

Abstract

Objective

The primary objective of this review is to examine the literature assessing abnormalities in neural circuitry and cognition early in the course of major depressive disorder (MDD) and the impact of these features on treatment selection and long-term outcomes.

Data Sources

English language and peer-reviewed publications were obtained by PubMed/Medline (www.pubmed.org) searches using combinations of major depressive disorder, major depression, or unipolar depression and ā€œfirst episodeā€, early, cognition, cognitive, executive function and memory. The terms bipolar and psychosis were excluded from the searches. These searches yielded 409 records.

Study selection

A total of 12 studies, systematic reviews and meta-analyses were selected that evaluated learning, memory and executive function in individuals with major depressive disorder. Additional publications meeting these criteria were identified from the bibliographies of the 12 selected articles and from the ā€œrelated citationsā€ section of PubMed.

Results

Difficulty in concentrating and indecisiveness are reported as among the most troubling symptoms by patients with MDD and may limit functional recovery. Cognitive deficits in memory and decision-making are present early in the course of MDD and may be accompanied by structural abnormalities in the hippocampus and prefrontal cortex involved in cognitive functions. Although resolution of cognitive symptoms of depression lags behind recovery from mood symptoms in many patients, preliminary evidence suggests they may improve with antidepressant therapy, but can also persist residually.

Conclusions

New strategies that target cognitive symptoms of depression in addition to mood symptoms are needed to improve long-term outcomes, particularly functional recovery.

Introduction

Cognitive symptoms are common among patients with major depressive disorder (MDD) (Fava et al., 2006, Lee et al., 2012, Wagner et al., 2012a, Murrough et al., 2011, Millan et al., 2012), although the true prevalence is not known. We do know cognitive difficulties associated with depression, such as memory impairment, difficulty making decisions, and loss of cognitive flexibility are associated with considerable disability and limited functional recovery (Jaeger et al., 2006, McCall and Dunn, 2003, Naismith et al., 2007). This is particularly troubling because these symptoms frequently persist after remission of a depressive episode (Hasselbalch et al., 2011, Herrera-Guzman et al., 2010, Weiland-Fiedler et al., 2004, Neu et al., 2005, Paelecke-Habermann et al., 2005, Clark et al., 2005, Marcos et al., 1994, Hammar et al., 2010, Airaksinen et al., 2006, Ardal and Hammar, 2011). Nonetheless, there is evidence that cognitive symptoms improve with antidepressant therapy (Wagner et al., 2012a, Herrera-Guzman et al., 2009), and preliminary results show that some classes of antidepressants may be more effective in improving specific cognitive symptoms than others (Herrera-Guzman et al., 2009). These findings suggest that functional outcomes should be monitored during treatment and raise the possibility that interventions which improve cognition may speed functional recovery in patients with MDD (Greer et al., 2010).

Many questions remain regarding the differential expression of cognitive impairment in patients with MDD, such as the timing and duration of their presence, the implications of their presence for long-term outcomes, and the role of treatment to mitigate these symptoms (Wagner et al., 2012a, Millan et al., 2012). This review will focus on: (1) cognitive deficits associated with depression, with an emphasis on those found early in the course of the disease, (2) the neural circuitry associated with cognition and its disruption in depression, (3) the impact of early cognitive dysfunction on recovery, and (4) the impact of antidepressant treatment on cognition. Additionally, the challenges in studying neurocognitive symptoms in patients with MDD will be discussed.

Section snippets

Methods

English language and peer-reviewed publications were obtained by PubMed/Medline (www.pubmed.org) searches. The search terms: major depressive disorder, major depression, and unipolar depression were combined with ā€œfirst episodeā€, early, cognition, cognitive, executive function and memory; searches excluded bipolar and psychosis and were limited to papers published in English. A total of 409 records were retrieved and manually screened to eliminate articles primarily discussing stroke,

Conclusions

Despite many challenges in study designs, substantial evidence shows that cognitive symptoms affect a large subset of patients with unipolar depression. Psychomotor speed, executive function and working memory are emerging as the most frequently reported symptoms. Symptoms are present early in the course of the disease and may precede onset of first episode. Nonetheless, antidepressants, particularly those that act at more than one receptor, appear to improve cognition in affected individuals.

Role of funding source

This work has been supported by Takeda Deerfield, IL and H. Lundbeck A/S, Valby DK

Disclaimer statements

Dr. Trivedi has received consulting fees from the following companies: Abbott Laboratories, Inc., Abdi Ibrahim, Akzo (Organon Pharmaceuticals Inc.), Alkermes, AstraZeneca, Axon Advisors, Bristol-Myers Squibb Company, Cephalon, Inc., CME Institute of Physicians, Eli Lilly & Company, Evotek, Fabre-Kramer Pharmaceuticals, Inc., Forest Pharmaceuticals, GlaxoSmithKline, Janssen Pharmaceutica Products, LP, Johnson & Johnson PRD, Libby, Lundbeck, Meade Johnson, MedAvante, Medtronic, Neuronetics,

Conflict of interest

No conflict declared.

Acknowledgments

This review was sponsored by the Takeda Pharmaceutical Company, Ltd. and H. Lundbeck A/S. Takeda and Lundbeck suggested the initial concept for the review and approached the lead author based on expertise in the field. Dr. Trivedi and Dr. Greer drafted and reviewed successive versions of the manuscript and had final control over content (neither company reviewed or provided comments on the manuscript content). Medical writing, editorial support, including styling and editing for journal

References (67)

  • I. Herrera-Guzman et al.

    Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder

    Psychiatry Research

    (2008)
  • I. Herrera-Guzman et al.

    Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder

    Journal of Psychiatric Research

    (2009)
  • I. Herrera-Guzman et al.

    Major Depressive Disorder in recovery and neuropsychological functioning: effects of selective serotonin reuptake inhibitor and dual inhibitor depression treatments on residual cognitive deficits in patients with Major Depressive Disorder in recovery

    Journal of Affective Disorders

    (2010)
  • J. Jaeger et al.

    Neurocognitive deficits and disability in major depressive disorder

    Psychiatry Research

    (2006)
  • J.G. Keilp et al.

    Attention deficit in depressed suicide attempters

    Psychiatry Research

    (2008)
  • G.C. Koetsier et al.

    CPT performance in major depressive disorder before and after treatment with imipramine or fluvoxamine

    Journal of Psychiatric Research.

    (2002)
  • I.K. Lampe et al.

    Effects of recurrent major depressive disorder on behavior and cognitive function in female depressed patients

    Psychiatry Research

    (2004)
  • R.S. Lee et al.

    A meta-analysis of cognitive deficits in first-episode Major Depressive Disorder

    Journal of Affective Disorders

    (2012)
  • F.T. Maalouf et al.

    Neurocognitive impairment in adolescent major depressive disorder: state vs. trait illness markers

    Journal of Affective Disorders

    (2011)
  • Z.N. Mannie et al.

    A functional magnetic resonance imaging study of verbal working memory in young people at increased familial risk of depression

    Biological Psychiatry

    (2010)
  • T. Marcos et al.

    Cognitive dysfunctions in recovered melancholic patients

    Journal of Affective Disorders

    (1994)
  • L.M. McDermott et al.

    A meta-analysis of depression severity and cognitive function

    Journal of Affective Disorders

    (2009)
  • J.W. Murrough et al.

    Cognitive dysfunction in depression: neurocircuitry and new therapeutic strategies

    Neurobiology of Learning and Memory

    (2011)
  • P. Neu et al.

    Cognitive function over the treatment course of depression in middle-aged patients: correlation with brain MRI signal hyperintensities

    Journal of Psychiatric Research.

    (2005)
  • Y. Paelecke-Habermann et al.

    Attention and executive functions in remitted major depression patients

    Journal of Affective Disorders

    (2005)
  • M. Vythilingam et al.

    Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment

    Biological Psychiatry

    (2004)
  • P. Weiland-Fiedler et al.

    Evidence for continuing neuropsychological impairments in depression

    Journal of Affective Disorders

    (2004)
  • X. Zhu et al.

    Altered white matter integrity in first-episode, treatment-naive young adults with major depressive disorder: a tract-based spatial statistics study

    Brain Research

    (2011)
  • E. Airaksinen et al.

    Cognitive functions in depressive disorders: evidence from a population-based study

    Psychological Medicine Psychological Medicine

    (2004)
  • E. Airaksinen et al.

    Low episodic memory performance as a premorbid marker of depression: evidence from a 3-year follow-up

    Acta Psychiatrica Scandinavica

    (2007)
  • G.S. Alexopoulos et al.

    Executive dysfunction and long-term outcomes of geriatric depression

    Archives of General Psychiatry

    (2000)
  • G. Ardal et al.

    Is impairment in cognitive inhibition in the acute phase of major depression irreversible? Results from a 10-year follow-up study

    Psychology and Psychotherapy

    (2011)
  • K.E. Burdick et al.

    The MATRICS consensus cognitive battery in patients with bipolar I disorder

    Neuropsychopharmacology

    (2011)
  • Cited by (225)

    • Mammillary body and hypothalamic volumes in mood disorders

      2023, Journal of Psychiatric Research
      Citation Excerpt :

      Finally, using high-resolution 7T magnetic resonance imaging (MRI) and image analysis techniques specifically designed for high-precision volumetry of the entire hypothalamus, we were able to observe a left-sided in vivo enlargement in MDD and BD (Schindler et al., 2019). Considering the cognitive deficits in mood disorders (Millan et al., 2012; Trivedi and Greer, 2014) and the limitations of the postmortem approach (Bernstein et al., 2012), we predicted an in vivo volume increase of the MBs in patients compared to controls. : Given the HPA axis dysregulation in stress-related psychiatric disorders (Kendler et al., 1999; Vreeburg et al., 2009; Keller et al., 2017; Mikulska et al., 2021) and the recent neuroimaging finding (Schindler et al., 2019), we also predicted an in vivo enlargement of the hypothalamus without MB (HTh) in patients with mood disorders relative to healthy controls.

    View all citing articles on Scopus
    View full text